We are live on
!
Find out more
MAM
Monaco Asset Management Portfolio holdings
AUM
$542M
1-Year Est. Return
54.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$334M
AUM Growth
-$5.65M
(-1.7%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-9.12%
Top 10 Holdings %
Top 10 Hldgs %
62.07%
Holding
89
New
11
Increased
12
Reduced
29
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$16.3M |
| 2 |
Viatris
VTRS
|
+$5.29M |
| 3 |
Zoom
ZM
|
+$5.07M |
| 4 |
Baidu
BIDU
|
+$3.01M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fate Therapeutics
FATE
|
+$11.6M |
| 2 |
Agnico Eagle Mines
AEM
|
+$8.05M |
| 3 |
Pfizer
PFE
|
+$5.76M |
| 4 |
PayPal
PYPL
|
+$4.54M |
| 5 |
B
Barrick Mining
B
|
+$4.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.24% |
| 2 | Materials | 18.8% |
| 3 | Technology | 6.47% |
| 4 | Communication Services | 3.47% |
| 5 | Consumer Discretionary | 2.43% |
Similar funds
BCB
WCA
ISB
CIAM
FMC
HCM
FSA
WW
Monaco Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Monaco Asset Management held 89 positions worth $334M, down 1.7% from $340M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Monaco Asset Management withdrew a net $30.5M in Q1 2024, closing 33 positions and reducing 29 holdings. Its most notable exit was Pfizer, an estimated $5.76M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Materials and Technology.
Against the trend, Monaco Asset Management opened a new position in VanEck Gold Miners ETF worth $18.2M.
- Monaco Asset Management's largest Q1 2024 buy was VanEck Gold Miners ETF: 574,500 shares worth $18.2M.
- Monaco Asset Management added most to Viatris in Q1 2024, an estimated $5.29M increase.
- Monaco Asset Management's biggest Q1 2024 reduction was Fate Therapeutics, cutting an estimated $11.6M.
- Monaco Asset Management fully exited Pfizer in Q1 2024, selling an estimated $5.76M.
- Monaco Asset Management's ten largest holdings make up 62% of its $334M portfolio in Q1 2024.
- Monaco Asset Management opened 11 new positions and closed 33 in Q1 2024.
- Monaco Asset Management's portfolio value fell 1.7% quarter-over-quarter to $334M.
Based on Monaco Asset Management's 13F filing for Q1 2024, filed 9 May 2024.